A new regulatory landscape and M&A activity created opportunities for the life sector in 2016, as more companies looked to the ILS sector to transfer risk.
The implementation of Actuarial Guideline 48 in the US established uniformity for reserve financing transactions, while Solvency II capital requirements came into effect on 1 January in Europe.
"Solvency II has been a game changer. We are beginning to see the first effects but it's only the tip of the iceberg," said Andrea Cavalleri,...
If you are a non-subscriber but would like to be able to view this article, then please go to our Publications page for further information on joining our readership